ERX-315

EtiraRx Australia Pty Ltd · Phase 1 active Small molecule

At a glance

Generic name	ERX-315
Sponsor	EtiraRx Australia Pty Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ERX-315 CI brief — competitive landscape report
ERX-315 updates RSS · CI watch RSS
EtiraRx Australia Pty Ltd portfolio CI